Nanjing Leads Biolabs Co., Ltd. (LEADS BIOLABS-B) (Stock Code: 09887) announced that, effective March 9, 2026, its shares will be included as a constituent stock of the Hang Seng Composite Index by Hang Seng Indexes Company Limited. Concurrently, the company’s shares will be added to the list of eligible securities under the Stock Connect Southbound Trading Link.
According to the announcement, this inclusion reflects capital market recognition of the company’s performance and value, enabling eligible mainland investors to invest in the company’s shares through the Shanghai Hong Kong Stock Connect and Shenzhen Hong Kong Stock Connect mechanisms. The listing is expected to enhance the company’s investor base and increase trading liquidity for its shares.
Comments